Literature DB >> 3182091

Use of ciprofloxacin in biliary sepsis.

C J Chrysanthopoulos, A T Skoutelis, J C Starakis, A Arvaniti, H P Bassaris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3182091     DOI： 10.1007/bf01650766

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  1 in total

1.  Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.

Authors:  T Bergan; S B Thorsteinsson; R Solberg; L Bjornskau; I M Kolstad; S Johnsen
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965
  1 in total
  5 in total

1.  Biliary tract infections treated with ciprofloxacin.

Authors:  G N Karachalios; G Zografos; V Patrikakos; D Nassopoulou; K Kehagioglou
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

2.  A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily.

Authors:  H Bassaris; E Akalin; S Calangu; R Kitzes; J Kosmidis; M Milicevic; H Noack; R Raz; E Salewski; M Sukalo
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

Review 3.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 4.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 5.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.